Budesonide/formoterol combination for reducing cough in COVID-19 patients—A case of inflated expectations!
Main Authors: | Onkardeep Kaur, Pawan Kumar Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Lung India |
Online Access: | http://www.lungindia.com/article.asp?issn=0970-2113;year=2023;volume=40;issue=5;spage=483;epage=483;aulast=Kaur |
Similar Items
-
Effectiveness of budesonide formoterol fixed-dose combination MDI in reducing cough symptoms in COVID-19 patients: A real-world evidence study
by: Shambo Samrat Samajdar, et al.
Published: (2023-01-01) -
Some aspects of application of the combination of formoterol and budesonide: what is changed?
by: A. A. Vizel, et al.
Published: (2019-12-01) -
COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
by: V. A. Nikitin, et al.
Published: (2016-03-01) -
Controlled trial of budesonide–formoterol as needed for mild asthma
by: Beasley, R, et al.
Published: (2019) -
Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
by: Hyun-moon Back, et al.
Published: (2020-04-01)